Semi-Annual Consolidated Statement Of Cash Flows

PhoenixBio Co.,Ltd. - Filing #7556538

Concept As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2021-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
413,815,000 JPY
510,644,000 JPY
-393,002,000 JPY
-160,891,000 JPY
Depreciation
23,700,000 JPY
86,238,000 JPY
Impairment losses
JPY
265,027,000 JPY
Interest expenses
3,072,000 JPY
952,000 JPY
Foreign exchange losses (gains)
-5,793,000 JPY
-5,951,000 JPY
Increase (decrease) in provision for bonuses
4,546,000 JPY
JPY
Decrease (increase) in inventories
-105,870,000 JPY
-19,018,000 JPY
Increase (decrease) in trade payables
2,344,000 JPY
-4,577,000 JPY
Other, net
506,000 JPY
3,190,000 JPY
Subtotal
277,362,000 JPY
12,751,000 JPY
Interest and dividends received
2,221,000 JPY
203,000 JPY
Interest paid
-3,072,000 JPY
-955,000 JPY
Income taxes paid
-12,118,000 JPY
-4,175,000 JPY
Net cash provided by (used in) operating activities
277,491,000 JPY
16,398,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-6,835,000 JPY
-6,771,000 JPY
Purchase of investment securities
-136,114,000 JPY
JPY
Other, net
-7,857,000 JPY
-203,000 JPY
Net cash provided by (used in) investing activities
-156,340,000 JPY
-6,975,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
JPY
-2,481,000 JPY
Net cash provided by (used in) financing activities
86,630,000 JPY
-34,658,000 JPY
Effect of exchange rate change on cash and cash equivalents
22,034,000 JPY
22,930,000 JPY
Net increase (decrease) in cash and cash equivalents
229,815,000 JPY
-2,305,000 JPY
Cash and cash equivalents
1,555,323,000 JPY
1,325,507,000 JPY
1,327,813,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.